SlideShare a Scribd company logo
1 of 53
Common skin ca
Tezazu Teffera Tekle
updated
December 2023
• Basal cell ca
• Squamous cell ca
• melanoma
• Basal cell carcinoma is the most common
human malignancy worldwide.
• It accounts for more than 75% of skin
cancers
• Primary Tumor (T)TXPrimary tumor cannot be assessedT0No
evidence of primary tumorTisCarcinoma in situ
• T1Tumor ≤2 cm in greatest dimension
• T2Tumor >2 cm, but not >5 cm, in greatest dimension
• T3Tumor >5 cm in greatest dimension
• T4Tumor invades deep extradermal structures (i.e., cartilage,
skeletal muscle, or bone)
• Regional Lymph Nodes (N)NXRegional lymph nodes cannot be
assessedN0No regional lymph node metastasis
• N1Regional lymph node metastasis
• Distant Metastasis (M)MXDistant metastasis cannot be
assessedM0No distant metastasisM1Distant metastasis
• Chronic exposure to sunlight is the
principal cause of basal cell carcinomas,
and thus lesions characteristically occur on
exposed parts of the body—the face, ears,
neck, scalp, shoulders, and back
• Superficial
• Nodular ulcerative the most common
• Sclerosing the most aggresive
• Pigmented
• Cystic
Option of managements
• Curettage and electro desiccation
• cryosurgery
• Topical 5-fluorouracil
• topical imiquimod, intralesional interfron
• , radiotherapy, or surgical excision.
• The same limitations of radiotherapy in
treatment of basal cell carcinoma are
applicable
• Mohs' micro surgery is the most definitive
modality and treatment of choice in high-
risk BCC of anatomically complex areas on
the face
SQUAMOUS CELL CARCINOMA
• Squamous cell carcinomas account for
20% of skin cancers
• Precipitating factor :sunlight, susceptible
phenotype, and compromised immunity, in
addition to environmental conditions and
diseases
• A Marjolin ulcer is a squamous cell
carcinoma that has developed in an
area of chronic inflammation and
scarring, which carries a risk of
metastasis of nearly 50%.
melanoma
Background
Definition: Malignant transformation of the melanocyte
It is the 4% all skin cancer It occurs most commonly on
the extremities in female and on trunk in male
But it can occur in eye ,GI tract mucosa ,sinus ,anus and
vagina that beyond our scope
Incidence, 15:100000
• 70% of death
• Common in Caucasian population
• it is the most common ca female age of 25-29year
Etiology and risk factor
• UV radiation
• Skin ,eye and hair color
• Actinic keratosis nonmelanoma skin ca
• History of sun burn
• Immunosuppression
• Family and personal history
• Mutation
• Xeroderma pigmentosis
• Atypical nevus
• Nevus more than 50-100
• Giant melanocytic nevus Size greater than 20cm
Clinical manifestation
• ABCDE rule
Warning sign
A asymmetry
B border irregularity
C color change
D diameter 6mm and above
E
• Ugly duckling sign
• ABCD rule fail in nodular melanoma
• Early Itching sensation
• Bleeding
• Change is key for diagnosis
• Different nevus from adjacent is suspicious
(difference)
• Photography
• Dermoscopy
• Early detection
Investigation
Sampling
• Excisional biopsy
• incisional biopsy
• Punch biopsy
Other
CXR
CBC
CT for head and neck
Alkaine phosphatase
LDH
PET
MRI of brain
Staging
Clinical staging based on clincal
and radilogical
CLINICAL STAGE GROUPING
Stage 0 Tis N0 M0
Stage IA T1a N0 M0
Stage IB T1b N0 M0
T2a N0 M0
Stage IIA T2b N0 M0
T3a N0 M0
Stage IIB T3b N0 M0
T4a N0 M0
Stage IIC T4b N0 M0
Stage III Any T N1 M0
Any T N2 M0
Any T N3 M0
Stage IV Any T Any N M1
• Pathological staging
Based on pathologic finding
Always after intervention
HISTOPATHOLOGIC TYPE
• Melanoma in situ
• Malignant melanoma, NOS
• Superficial spreading melanoma
• Nodular melanoma
• Lentigo maligna melanoma
• Acral lentiginous melanoma,
• Desmoplastic melanoma,
• Epithelioid cell melanoma
• Spindle cell melanoma
• Balloon cell melanoma
• Blue nevus, malignant
• Malignant melanoma in giant pigmented n
Surgical management
• Wide local excision
Handley idea
Current recommendation
Less than 1mm 1cm
1-2mm 1-2cm
2-4mm 2cm
Greater than 4mm 2-3cm
Unusal surgical managment
• Subungual melanoma
• Ear melanma
Lymphadenectomy
• Clinically involved
• there is controversy about ELND
• Sentile lymphnode biopsy
Adjuvant therapy
• IFN  for stage 2b and 3
Radiotherapy indicated for secondary brain
and bone
Chemotherapy
• The best response observed on singe
agent
• ILP combination of melphalan ,TNF and
INF-α
Immunotherapy and
biochemotherapy
Our Patient
• Ignorance and negligence
• Poor knowledge and awarence
• Limitation health facility
• Poverty
Skin Ca revised 2023.ppt
Skin Ca revised 2023.ppt
Skin Ca revised 2023.ppt
Skin Ca revised 2023.ppt
Skin Ca revised 2023.ppt
Skin Ca revised 2023.ppt
Skin Ca revised 2023.ppt

More Related Content

Similar to Skin Ca revised 2023.ppt

skin and subcutaneous swelling presentation
skin and subcutaneous swelling  presentationskin and subcutaneous swelling  presentation
skin and subcutaneous swelling presentationthanaram patel
 
SALIVORY GLAND FINAL YR.pptx
SALIVORY GLAND FINAL YR.pptxSALIVORY GLAND FINAL YR.pptx
SALIVORY GLAND FINAL YR.pptxafzal mohd
 
Skin tumours
Skin tumoursSkin tumours
Skin tumoursSuhas U
 
Malignant Melanoma.pptx
Malignant Melanoma.pptxMalignant Melanoma.pptx
Malignant Melanoma.pptxOlofin Kayode
 
Skin Cancer disease detailed review and information
Skin Cancer disease detailed review and informationSkin Cancer disease detailed review and information
Skin Cancer disease detailed review and informationGauravGautam216125
 
Tumours of external and middle ear
Tumours of external and middle earTumours of external and middle ear
Tumours of external and middle earRamesh Parajuli
 
melanoma (2).pptx
melanoma (2).pptxmelanoma (2).pptx
melanoma (2).pptxAl Mamun
 
summary of all pathology_LT………………………...pdf
summary of all pathology_LT………………………...pdfsummary of all pathology_LT………………………...pdf
summary of all pathology_LT………………………...pdfr8fdq7w2m9
 
Cutaneous malignancies and related disorders.pptx
Cutaneous malignancies and related disorders.pptxCutaneous malignancies and related disorders.pptx
Cutaneous malignancies and related disorders.pptxAjilAntony10
 
Melanoma clinical features, pathology and management
Melanoma clinical features, pathology and managementMelanoma clinical features, pathology and management
Melanoma clinical features, pathology and managementsanyal1981
 
Neoplasms of nose and paranasal sinuses
Neoplasms of nose and paranasal sinuses Neoplasms of nose and paranasal sinuses
Neoplasms of nose and paranasal sinuses krishnakoirala4
 
Neoplasms of nose and pns
Neoplasms of nose and pnsNeoplasms of nose and pns
Neoplasms of nose and pnskrishnakoirala4
 
835013767-6701662004782059.pptx
835013767-6701662004782059.pptx835013767-6701662004782059.pptx
835013767-6701662004782059.pptxPariaMotahari1
 
Radiation oncology in ent- Dr santhosh,ENT -vizag
Radiation oncology in ent- Dr santhosh,ENT -vizagRadiation oncology in ent- Dr santhosh,ENT -vizag
Radiation oncology in ent- Dr santhosh,ENT -vizagSanthoshbabuslides
 

Similar to Skin Ca revised 2023.ppt (20)

skin and subcutaneous swelling presentation
skin and subcutaneous swelling  presentationskin and subcutaneous swelling  presentation
skin and subcutaneous swelling presentation
 
SALIVORY GLAND FINAL YR.pptx
SALIVORY GLAND FINAL YR.pptxSALIVORY GLAND FINAL YR.pptx
SALIVORY GLAND FINAL YR.pptx
 
Skin tumours
Skin tumoursSkin tumours
Skin tumours
 
Malignant Melanoma.pptx
Malignant Melanoma.pptxMalignant Melanoma.pptx
Malignant Melanoma.pptx
 
Skin Cancer disease detailed review and information
Skin Cancer disease detailed review and informationSkin Cancer disease detailed review and information
Skin Cancer disease detailed review and information
 
Skin cancers
Skin cancersSkin cancers
Skin cancers
 
Tumours of external and middle ear
Tumours of external and middle earTumours of external and middle ear
Tumours of external and middle ear
 
Malignant skin diseases
Malignant skin diseasesMalignant skin diseases
Malignant skin diseases
 
melanoma (2).pptx
melanoma (2).pptxmelanoma (2).pptx
melanoma (2).pptx
 
Sinonasal Tumours - Okoye
Sinonasal Tumours - OkoyeSinonasal Tumours - Okoye
Sinonasal Tumours - Okoye
 
Management of throid cancer
Management of throid cancerManagement of throid cancer
Management of throid cancer
 
Seminar ca penis
Seminar ca penisSeminar ca penis
Seminar ca penis
 
summary of all pathology_LT………………………...pdf
summary of all pathology_LT………………………...pdfsummary of all pathology_LT………………………...pdf
summary of all pathology_LT………………………...pdf
 
Cutaneous malignancies and related disorders.pptx
Cutaneous malignancies and related disorders.pptxCutaneous malignancies and related disorders.pptx
Cutaneous malignancies and related disorders.pptx
 
Melanoma clinical features, pathology and management
Melanoma clinical features, pathology and managementMelanoma clinical features, pathology and management
Melanoma clinical features, pathology and management
 
Neoplasms of nose and paranasal sinuses
Neoplasms of nose and paranasal sinuses Neoplasms of nose and paranasal sinuses
Neoplasms of nose and paranasal sinuses
 
Neoplasms of nose and pns
Neoplasms of nose and pnsNeoplasms of nose and pns
Neoplasms of nose and pns
 
Parotid
ParotidParotid
Parotid
 
835013767-6701662004782059.pptx
835013767-6701662004782059.pptx835013767-6701662004782059.pptx
835013767-6701662004782059.pptx
 
Radiation oncology in ent- Dr santhosh,ENT -vizag
Radiation oncology in ent- Dr santhosh,ENT -vizagRadiation oncology in ent- Dr santhosh,ENT -vizag
Radiation oncology in ent- Dr santhosh,ENT -vizag
 

Recently uploaded

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13Steve Thomason
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfakmcokerachita
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon AUnboundStockton
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Educationpboyjonauth
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfUmakantAnnand
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docxPoojaSen20
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxiammrhaywood
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesFatimaKhan178732
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Krashi Coaching
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxOH TEIK BIN
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxSayali Powar
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactdawncurless
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityGeoBlogs
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)eniolaolutunde
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...Marc Dusseiller Dusjagr
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxmanuelaromero2013
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdfssuser54595a
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfsanyamsingh5019
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsanshu789521
 

Recently uploaded (20)

The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13The Most Excellent Way | 1 Corinthians 13
The Most Excellent Way | 1 Corinthians 13
 
Class 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdfClass 11 Legal Studies Ch-1 Concept of State .pdf
Class 11 Legal Studies Ch-1 Concept of State .pdf
 
Crayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon ACrayon Activity Handout For the Crayon A
Crayon Activity Handout For the Crayon A
 
Introduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher EducationIntroduction to ArtificiaI Intelligence in Higher Education
Introduction to ArtificiaI Intelligence in Higher Education
 
Concept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.CompdfConcept of Vouching. B.Com(Hons) /B.Compdf
Concept of Vouching. B.Com(Hons) /B.Compdf
 
mini mental status format.docx
mini    mental       status     format.docxmini    mental       status     format.docx
mini mental status format.docx
 
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptxSOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
SOCIAL AND HISTORICAL CONTEXT - LFTVD.pptx
 
Separation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and ActinidesSeparation of Lanthanides/ Lanthanides and Actinides
Separation of Lanthanides/ Lanthanides and Actinides
 
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝Model Call Girl in Bikash Puri  Delhi reach out to us at 🔝9953056974🔝
Model Call Girl in Bikash Puri Delhi reach out to us at 🔝9953056974🔝
 
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
Kisan Call Centre - To harness potential of ICT in Agriculture by answer farm...
 
Solving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptxSolving Puzzles Benefits Everyone (English).pptx
Solving Puzzles Benefits Everyone (English).pptx
 
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptxPOINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
POINT- BIOCHEMISTRY SEM 2 ENZYMES UNIT 5.pptx
 
Accessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impactAccessible design: Minimum effort, maximum impact
Accessible design: Minimum effort, maximum impact
 
Paris 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activityParis 2024 Olympic Geographies - an activity
Paris 2024 Olympic Geographies - an activity
 
Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)Software Engineering Methodologies (overview)
Software Engineering Methodologies (overview)
 
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
“Oh GOSH! Reflecting on Hackteria's Collaborative Practices in a Global Do-It...
 
How to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptxHow to Make a Pirate ship Primary Education.pptx
How to Make a Pirate ship Primary Education.pptx
 
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
18-04-UA_REPORT_MEDIALITERAСY_INDEX-DM_23-1-final-eng.pdf
 
Sanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdfSanyam Choudhary Chemistry practical.pdf
Sanyam Choudhary Chemistry practical.pdf
 
Presiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha electionsPresiding Officer Training module 2024 lok sabha elections
Presiding Officer Training module 2024 lok sabha elections
 

Skin Ca revised 2023.ppt

  • 1. Common skin ca Tezazu Teffera Tekle updated December 2023
  • 2. • Basal cell ca • Squamous cell ca • melanoma
  • 3. • Basal cell carcinoma is the most common human malignancy worldwide. • It accounts for more than 75% of skin cancers
  • 4.
  • 5. • Primary Tumor (T)TXPrimary tumor cannot be assessedT0No evidence of primary tumorTisCarcinoma in situ • T1Tumor ≤2 cm in greatest dimension • T2Tumor >2 cm, but not >5 cm, in greatest dimension • T3Tumor >5 cm in greatest dimension • T4Tumor invades deep extradermal structures (i.e., cartilage, skeletal muscle, or bone) • Regional Lymph Nodes (N)NXRegional lymph nodes cannot be assessedN0No regional lymph node metastasis • N1Regional lymph node metastasis • Distant Metastasis (M)MXDistant metastasis cannot be assessedM0No distant metastasisM1Distant metastasis
  • 6. • Chronic exposure to sunlight is the principal cause of basal cell carcinomas, and thus lesions characteristically occur on exposed parts of the body—the face, ears, neck, scalp, shoulders, and back
  • 7. • Superficial • Nodular ulcerative the most common • Sclerosing the most aggresive • Pigmented • Cystic
  • 8.
  • 9.
  • 10.
  • 11.
  • 12. Option of managements • Curettage and electro desiccation • cryosurgery • Topical 5-fluorouracil • topical imiquimod, intralesional interfron • , radiotherapy, or surgical excision. • The same limitations of radiotherapy in treatment of basal cell carcinoma are applicable
  • 13. • Mohs' micro surgery is the most definitive modality and treatment of choice in high- risk BCC of anatomically complex areas on the face
  • 14. SQUAMOUS CELL CARCINOMA • Squamous cell carcinomas account for 20% of skin cancers • Precipitating factor :sunlight, susceptible phenotype, and compromised immunity, in addition to environmental conditions and diseases
  • 15. • A Marjolin ulcer is a squamous cell carcinoma that has developed in an area of chronic inflammation and scarring, which carries a risk of metastasis of nearly 50%.
  • 16.
  • 17.
  • 18.
  • 19.
  • 20.
  • 21.
  • 22.
  • 23.
  • 24.
  • 25.
  • 26.
  • 27.
  • 28.
  • 29.
  • 31. Background Definition: Malignant transformation of the melanocyte It is the 4% all skin cancer It occurs most commonly on the extremities in female and on trunk in male But it can occur in eye ,GI tract mucosa ,sinus ,anus and vagina that beyond our scope Incidence, 15:100000 • 70% of death • Common in Caucasian population • it is the most common ca female age of 25-29year
  • 32. Etiology and risk factor • UV radiation • Skin ,eye and hair color • Actinic keratosis nonmelanoma skin ca • History of sun burn • Immunosuppression • Family and personal history • Mutation • Xeroderma pigmentosis • Atypical nevus • Nevus more than 50-100 • Giant melanocytic nevus Size greater than 20cm
  • 33.
  • 34. Clinical manifestation • ABCDE rule Warning sign A asymmetry B border irregularity C color change D diameter 6mm and above E
  • 35. • Ugly duckling sign • ABCD rule fail in nodular melanoma • Early Itching sensation • Bleeding • Change is key for diagnosis • Different nevus from adjacent is suspicious (difference) • Photography • Dermoscopy • Early detection
  • 36. Investigation Sampling • Excisional biopsy • incisional biopsy • Punch biopsy Other CXR CBC CT for head and neck Alkaine phosphatase LDH PET MRI of brain
  • 37. Staging Clinical staging based on clincal and radilogical CLINICAL STAGE GROUPING Stage 0 Tis N0 M0 Stage IA T1a N0 M0 Stage IB T1b N0 M0 T2a N0 M0 Stage IIA T2b N0 M0 T3a N0 M0 Stage IIB T3b N0 M0 T4a N0 M0 Stage IIC T4b N0 M0 Stage III Any T N1 M0 Any T N2 M0 Any T N3 M0 Stage IV Any T Any N M1
  • 38. • Pathological staging Based on pathologic finding Always after intervention
  • 39. HISTOPATHOLOGIC TYPE • Melanoma in situ • Malignant melanoma, NOS • Superficial spreading melanoma • Nodular melanoma • Lentigo maligna melanoma • Acral lentiginous melanoma, • Desmoplastic melanoma, • Epithelioid cell melanoma • Spindle cell melanoma • Balloon cell melanoma • Blue nevus, malignant • Malignant melanoma in giant pigmented n
  • 40. Surgical management • Wide local excision Handley idea Current recommendation Less than 1mm 1cm 1-2mm 1-2cm 2-4mm 2cm Greater than 4mm 2-3cm
  • 41. Unusal surgical managment • Subungual melanoma • Ear melanma
  • 42. Lymphadenectomy • Clinically involved • there is controversy about ELND • Sentile lymphnode biopsy
  • 43. Adjuvant therapy • IFN  for stage 2b and 3 Radiotherapy indicated for secondary brain and bone
  • 44. Chemotherapy • The best response observed on singe agent • ILP combination of melphalan ,TNF and INF-α
  • 46. Our Patient • Ignorance and negligence • Poor knowledge and awarence • Limitation health facility • Poverty